{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:42:16Z","timestamp":1773175336732,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.msard.2024.105857","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T06:43:10Z","timestamp":1726468990000},"page":"105857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Macular vascular density alteration patterns in paediatric optic neuritis patients with serum MOG antibody positivity detected by optic coherence tomography angiography"],"prefix":"10.1016","volume":"91","author":[{"given":"Chunxia","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2024.105857_bib0001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/ijms22010100","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management","volume":"22","author":"Ambrosius","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2024.105857_bib0002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105857_bib0003","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Banwell","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105857_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42201","article-title":"Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography","volume":"7","author":"Campbell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2024.105857_bib0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fneur.2020.00542","article-title":"Peripapillary vessel density as early biomarker in multiple sclerosis","volume":"11","author":"Cennamo","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105857_bib0006","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.spen.2017.04.004","article-title":"Pediatric optic neuritis","volume":"24","author":"Chang","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.msard.2024.105857_bib0007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2024.105857_bib0008","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of myelin oligodendrocyte glycoprotein and aquaporin-4-IgG in patients in the optic neuritis treatment trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.msard.2024.105857_bib0009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2018.03.003","article-title":"Clinical characteristics of pediatric optic neuritis with myelin oligodendrocyte glycoprotein seropositive: a cohort study","volume":"83","author":"Chen","year":"2018","journal-title":"Pediatr. Neurol."},{"issue":"15","key":"10.1016\/j.msard.2024.105857_bib0010","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.3390\/ijms22157925","article-title":"Cells to the rescue: emerging cell-based treatment approaches for NMOSD and MOGAD","volume":"22","author":"Derdelinckx","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.msard.2024.105857_bib0011","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1073\/pnas.1222560110","article-title":"Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1","volume":"110","author":"D'haeseleer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.msard.2024.105857_bib0012","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder","author":"Dos Passos","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105857_bib0013","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ophtha.2012.07.066","article-title":"Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography","volume":"120","author":"Fernandes","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.msard.2024.105857_bib0014","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.105857_bib0015","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and clinical characteristics of optic neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2024.105857_bib0016","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.preteyeres.2017.11.002","article-title":"Retinal energy demands control vascular supply of the retina in development and disease: the role of neuronal lipid and glucose metabolism","volume":"64","author":"Joyal","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"12","key":"10.1016\/j.msard.2024.105857_bib0017","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.msard.2024.105857_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.604049","article-title":"Optical coherence tomography angiography (OCTA) in multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"11","author":"Kleerekooper","year":"2020","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2024.105857_bib0019","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2024.105857_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918774800","article-title":"Impaired cerebral perfusion in multiple sclerosis: relevance of endothelial factors","volume":"13","author":"Monti","year":"2018","journal-title":"Biomark. Insights"},{"issue":"7","key":"10.1016\/j.msard.2024.105857_bib0021","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/1352458519845116","article-title":"Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures","volume":"26","author":"Murphy","year":"2020","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2024.105857_bib0022","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/aos.13257","article-title":"Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode","volume":"95","author":"Peng","year":"2017","journal-title":"Acta Ophthalmol."},{"issue":"6","key":"10.1016\/j.msard.2024.105857_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157645","article-title":"Structural alterations of segmented macular inner layers in Aquaporin4-antibody-positive optic neuritis patients in a Chinese population","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.msard.2024.105857_bib0024","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105857_bib0025","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1038\/s41598-021-90036-6","article-title":"Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using optical coherence tomography angiography","volume":"11","author":"Rogaczewska","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2024.105857_bib0026","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1352458514538110","article-title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria","volume":"21","author":"Schippling","year":"2015","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2024.105857_bib0027","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities ``hand motion'' and ``counting fingers'' can be quantified with the Freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.msard.2024.105857_bib0028","doi-asserted-by":"crossref","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.msard.2024.105857_bib0029","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"Experience of the optic neuritis treatment trial. Optic neuritis study group","volume":"109","author":"The clinical profile of optic neuritis","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.msard.2024.105857_bib0030","article-title":"Superficial macula capillary complexity changes are associated with disability in neuromyelitis","volume":"12","author":"Wei","year":"2021","journal-title":"Opt. Spectr. Disord. Front. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2024.105857_bib0031","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody disease","volume":"266","author":"Wynford-Thomas","year":"2019","journal-title":"J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:29:58Z","timestamp":1732336198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824004346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"alternative-id":["S2211034824004346"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105857","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macular vascular density alteration patterns in paediatric optic neuritis patients with serum MOG antibody positivity detected by optic coherence tomography angiography","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105857"}}